MMP2 and breast cancer: Our current finding of miR-137 suppression of MMP-2 expression, in conjunction with our previous discovery that ISO, via the induction of miR-137, inhibited BC invasion and BC growth in vitro and in vivo,7, 12 releases the nature of ISO as a potent BC therapeutic agent.